講演者

Speakers Line-up

Bertil Lindmark
Chief Scientific Officer, ASLAN Pharmaceuticals, Singapore

Takashi Kohno
Chief, Division of Genome Biology Research Institute, National Cancer Center Research Institute, Japan
Takahiro Ochiya
Chief, Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Japan

Shiro Akinaga
Fellow, Research and Development Division, Kyowa Hakko Kirin Co. Ltd., Japan

Gaël Le Rouzo
Business Director, Jazz Pharmaceuticals, France

George Chen
Director, Biomedical Sensing & Oncology Lab, Professor, Institute of Biomedical Engineering, Department of Biological Science and Technology, National Chiao Tung University, Taiwan

Dr. M. C. Fung
Vice-President, Oncology Scientific Innovation, J&J Asia-Pacific Innovation Center, China

Ming Ji
Senior Medical Director, Medical Safety Evaluation, AbbVie Global R&D, USA

Koichi Okuma
Executive Director, Strategic Marketing, Head of Oncology TA, Product Marketing Department, Astellas Pharma Inc., Japan

Simon Collier
Director General, European Federation of Pharmaceutical Industries and Associations Japan, Director, Government Affairs, Bayer Yakuhin Ltd., Japan

Takato Noumi
Director, External Science & Partnering, Sanofi Global R&D, Japan
Liang Schweizer
Head of Asian Cancer Research, Asia Pacific Research, Sanofi R&D, China

Jean-Francois Baladi
Senior Executive Officer, Health Economics & Outcomes Research, Oncology Business Unit, Novartis Pharmaceuticals, Japan

Martina Sersch
Senior Medical Director, Asia Pacific Bio-therapeutics Lead, Global Development Clinical Lead, Oncology TA, Roche Pharmaceuticals, China & USA

Satoshi Koike
Director, Global Regulatory Affairs, Amgen-Astellas Biopharma KK, Japan

Michael Lyons
Innovation & Capability Leader, Oncology Business Unit, Eli Lilly K, Japan

Jun Bao
Senior Vice President and Chief Business Officer, Shenogen Pharma Group, China

Tomoko Hirohashi
Director, Japan Development Leader, Oncology, Clinical Research, Pfizer Japan Inc., Japan

Alex Matter
Former Global Head of Research, Novartis Oncology, Chief Executive Officer, Experimental Therapeutics Centre, A*Star, Singapore

Jonghwa Won
Senior Research Director,  Mogam Biotechnology Research Institute, Green Cross Corp., Korea

Shin Jae Chang
Vice President, R&D, Celltrion, Korea

Jin San Yoo
President and CEO, PharmAbcine, Korea

Yoshiya Oda
President, Biomarkers & Personalized Medicine Unit, Eisai Inc, USA & Japan

Toshio Miyata
Executive Director, Health and Global Policy Institute, Japan

Ting Xu
Chief Executive Officer, Alphamab, China

Pabel Delgado
President & CEO, Asterism Healthcare GK, Japan

Xueming Qian
Chairman and Chief Executive Officer, Mabspace Biosciences, China
Kenji Watanabe
Clinical Oncologist, Director, Professor, Faculty of Environment and Information Study, Keio University School of Medicine, Japan

 

Produced bySupporting Associations 

 
Media Partners